Lv1
40 积分 2024-01-31 加入
The mechanisms and countermeasures for CAR-T cell expansion and persistence deficiency
7小时前
待确认
Synergizing hypomethylating agents with off-the-shelf CD70-targeted chimeric antigen receptor-engineered natural killer T cells for the treatment of acute myeloid leukemia
1天前
已完结
Fisetin Promotes Functional Recovery after Spinal Cord Injury by Inhibiting Microglia/Macrophage M1 Polarization and JAK2/STAT3 Signaling Pathway
1天前
已完结
CD70 CAR T cells secreting an anti-CD33/anti-CD3 dual-targeting antibody overcome antigen heterogeneity in AML
4天前
已完结
Fungal-derived cellobiose metabolic pathway fuels T cells to bypass intratumoral glucose competition
18天前
已完结
Disulfide-Directed Multicyclic Peptides for Chimeric Antigen Receptors Targeting Solid Tumors
20天前
已完结
Deep generative models design mRNA sequences with enhanced translational capacity and stability
27天前
已完结
Venetoclax in biomarker‐selected multiple myeloma patients: Impact of exposure on clinical efficacy and safety
28天前
已完结
Venetoclax or placebo in combination with bortezomib and dexamethasone in relapsed or refractory multiple myeloma (BELLINI): final overall survival results from a randomised, phase 3 study
28天前
已完结
Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial
28天前
已完结
皖公网安备34019202002308
